Adaptive and Collaborators to Present More than 30 Abstracts at 2023 ASH Annual Meeting

Read More

Acalabrutinib with Rituximab As First-Line Therapy for Older Patients with Mantle Cell Lymphoma: a Phase II Clinical Trial